What Actually Happens Before, During, and After Open Heart Surgery
Perioperative care is simply the three-phase bundle around a cardiac procedure. It covers preoperative optimization, intraoperative management, and postoperative recovery. Nobody disputes the definition. The disagreements show up when you look at how each phase is handled across different institutions. Protocols vary. Outcomes vary. A lot of the variability comes from how well teams integrate the three phases instead of treating them as separate checklists. The phrase sits awkwardly in any sentence. That is not a new problem. People use it when writing guidelines, audit reports, and quality improvement documents because it is shorthand for everything between admission and discharge. It also tends to get stretched into scope creep. You see it applied to outpatient valve clinics or hybrid procedures without acknowledging that the original framework was built around sternotomy and cardiopulmonary bypass. For modern practice, I treat it as a time window, not a procedure type. That distinction matters more than most people realize when they try to apply textbook protocols to patients who do not fit the textbook. I have spent years watching institutions struggle with the gap between protocol and reality. The gap is not usually caused by bad intent. It is caused by assuming a single pathway works for every patient. It does not. The real work happens in the details.
Preoperative Phase
This is where most avoidable complications are won or lost before the patient reaches the operating room. The first principle is risk stratification that actually means something. EuroSCORE II and STS scores are standard. They give you a number. Numbers are useful. They do not replace clinical judgment. I remember a patient who had a STS mortality estimate under 1 percent and still ended up with prolonged ventilation and acute kidney injury. The reason was not surgical error. It was an underappreciated combination of severe pulmonary hypertension and marginal left ventricular function that the score did not weight heavily enough for that specific case profile. Preoperative optimization should address these factors directly.
- Cardiac: Echocardiography to stage valvular disease, quantify ventricular function, and assess pulmonary pressures. Coronary anatomy via angiography. Rhythm evaluation with ECG and ambulatory monitoring if arrhythmia is suspected.
- Pulmonary: Spirometry for high-risk patients. Smoking cessation counseling for at least four weeks before surgery when possible.
- Renal: Baseline creatinine and estimated glomerular filtration rate. Identification of chronic kidney disease that may alter anticoagulation and perfusion strategies.
- Hematologic: Full blood count, coagulation profile, and iron studies. Anemia management before elective procedures reduces transfusion requirements.
- Metabolic: Glycemic control in diabetic patients. Thyroid function in patients with atrial fibrillation or unexplained cardiomyopathy.
- Infection screening: Nasal swab for Staphylococcus aureus, urine culture for symptomatic patients, dental evaluation when prolonged cardiopulmonary bypass is anticipated.
Prehabilitation
Prehabilitation is not just exercise. It is a structured program that includes nutritional support, physical conditioning, and psychological preparation. Evidence supports its use in reducing postoperative complications and shortening intensive care unit stays. The programs that work best are started at least two weeks before surgery and tailored to the individual patient's baseline function. The intraoperative period is where the surgical team takes over. Anesthesia, perfusion, and surgery must function as a coordinated unit. Communication breakdowns during this phase are a leading cause of adverse events. Standard monitoring includes invasive arterial pressure, central venous access, transesophageal echocardiography, and cardiac output monitoring. Temperature management is critical. Mild hypothermia during cardiopulmonary bypass reduces metabolic demand but increases bleeding risk. The balance depends on the procedure complexity and patient factors.
Get the Full Details
My approach to anesthetic management prioritizes hemodynamic stability over aggressive drug regimens. I have seen teams chase target pressures with vasoactive drugs while the underlying problem was inadequate preload or ventricular dysfunction. Fixing the physiology usually resolves the hemodynamic issue without escalating drug doses.
Cardiopulmonary Bypass Considerations
Perfusion management involves anticoagulation with heparin, monitored by activated clotting time. Target ACT is typically above 480 seconds. Hemodilution during bypass affects oxygen-carrying capacity and viscosity. Target hematocrit values between 20 and 24 percent are commonly used, though individual patient factors may warrant adjustments. Brain protection during aortic cross-clamping relies on cardioplegia. Antegrade and retrograde delivery advantages. The choice depends on coronary anatomy and surgical requirements. Myofocardial protection protocols have evolved significantly. Current practices emphasize warm blood cardioplegia in many centers, though cold blood cardioplegia remains standard in others. The evidence does not strongly favor one approach across all patient populations.
Postoperative Phase
This is where the perioperative bundle comes together. The intensive care unit stay sets the trajectory for recovery. After cardiac surgery, patients require close monitoring in an intensive care setting. Vital signs, urine output, and neurological status are tracked continuously. Bleeding is assessed through chest tube drainage. Blood products are administered based on standardized transfusion protocols. Pain management is essential for effective breathing and early mobilization. Multimodal analgesia combining opioids, non-steroidal anti-inflammatory drugs when appropriate, and regional techniques reduces opioid requirements and their associated side effects.
Complication Prevention
Common postoperative complications include atrial fibrillation, bleeding, renal dysfunction, and pneumonia. Prophylactic strategies exist for most of these. Atrial fibrillation occurs in approximately 20 to 40 percent of patients after cardiac surgery. Beta-blockers and amiodarone reduce incidence when started appropriately. Renal protection involves maintaining adequate perfusion pressure, avoiding nephrotoxic agents, and minimizing contrast exposure during preoperative imaging when possible. Lung protection includes early extubation when feasible, incentive spirometry, and adequate pain control to enable deep breathing.
Recovery and Discharge Planning
Discharge planning begins on admission. Recovery timelines vary based on surgical complexity and patient comorbidities. Most uncomplicated coronary artery bypass graft patients remain in the hospital five to seven days. Valve surgery may require longer stays. Patient education about wound care, activity progression, and medication adherence is essential for successful recovery at home. Tracking outcomes across the perioperative continuum helps identify areas for improvement. Mortality rates, complication rates, readmission rates, and patient-reported outcomes are standard metrics. Benchmarking against national databases provides context for institutional performance. What is often overlooked is the impact of process measures on outcomes. Consistent use of evidence-based bundles, such as glycemic control protocols and early mobilization programs, correlates with better results. The challenge is maintaining compliance across all providers and shifts.
Early Rehabilitation Protocols
Enhanced recovery pathways that include early feeding, early mobilization, and minimized opioid use have shown benefit in cardiac surgical populations. These protocols require coordinated effort across nursing, physiotherapy, and medical teams. When implemented consistently, they can reduce intensive care unit length of stay and overall hospital duration without increasing readmission rates. No perioperative protocol works for every patient. There are important limitations to acknowledge. Risk prediction models, despite their widespread use, have significant limitations. They are derived from population data and may not accurately predict outcomes for individual patients with unusual comorbidities or anatomical variations. Overreliance on these scores can lead to either inappropriate risk acceptance or avoidance of beneficial surgery.
Transfusion practices remain contentious. Restrictive strategies generally show non-inferiority to liberal approaches, but specific patient populations, such as those with severe coronary disease or ongoing ischemia, may benefit from higher hemoglobin thresholds. The evidence is not uniform across all subgroups. Extended care pathways for selected low-risk patients are being studied. Some centers report success with fast-track protocols that allow earlier discharge. These approaches require careful patient selection and robust follow-up systems. They are not suitable for all institutions or all patient populations.
Practical Implementation
Implementing comprehensive perioperative care requires institutional commitment. Leadership support, multidisciplinary collaboration, and continuous quality monitoring are necessary components. Standardized order sets and clinical pathways help ensure consistency but should allow for individualization when clinical circumstances warrant. Staff education and training are ongoing requirements. New evidence emerges regularly, and protocols need periodic review and update. Audit and feedback cycles help maintain adherence to evidence-based practices. Patient involvement in decision-making improves outcomes. When patients understand the perioperative process, their expectations are more realistic, and their engagement in recovery activities increases. Education materials and preoperative consultations serve this purpose effectively.
Monitoring and Follow-up
Postdischarge monitoring is an essential component of perioperative care that is frequently underemphasized. Scheduled follow-up visits, telephone contact, and access to clinical services support early detection of complications and continuity of care. Patient-reported outcome measures are increasingly recognized as important endpoints beyond traditional clinical metrics. The transition from hospital to home requires clear communication between teams. Medication reconciliation, activity recommendations, and warning signs that should prompt medical attention need to be documented and communicated to the patient and their primary care provider.
